These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, Nievelstein RA. Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400 [Abstract] [Full Text] [Related]
23. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L. Skeletal Radiol; 2012 Mar; 41(3):249-56. PubMed ID: 22072239 [Abstract] [Full Text] [Related]
25. Bone marrow aspirations in Ewing sarcomas: Are they still necessary? A single-center retrospective analysis and review of the literature. Breitegger B, Holzer LA, Beham-Schmid C, Urban C, Liegl-Atzwanger B, Leithner A. J Cancer Res Ther; 2020 Apr; 16(4):713-717. PubMed ID: 32930108 [Abstract] [Full Text] [Related]
26. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma. Albano D, Dondi F, Schumacher RF, D'Ippolito C, Porta F, Giubbini R, Bertagna F. J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716 [Abstract] [Full Text] [Related]
27. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F. J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [Abstract] [Full Text] [Related]
28. Prognostic Importance of Bone Marrow Uptake on Baseline 18F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma. Soydal C, Koksoy EB, Yasar A, Turgal E, Erdogan BD, Akbulut H, Kucuk NO. Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [Abstract] [Full Text] [Related]
29. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging. Evangelista L, Panunzio A, Polverosi R, Ferretti A, Chondrogiannis S, Pomerri F, Rubello D, Muzzio PC. Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054 [Abstract] [Full Text] [Related]
30. Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM. Pediatr Radiol; 2017 Jan; 47(1):82-88. PubMed ID: 27815616 [Abstract] [Full Text] [Related]
31. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up. Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schöder H. AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251 [Abstract] [Full Text] [Related]
32. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma. Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF. Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235 [Abstract] [Full Text] [Related]
33. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India. Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T. Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514 [Abstract] [Full Text] [Related]
34. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H. J Clin Oncol; 2007 Dec 01; 25(34):5435-41. PubMed ID: 18048826 [Abstract] [Full Text] [Related]
36. F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study. Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM. Clin Physiol Funct Imaging; 2016 Nov 01; 36(6):441-446. PubMed ID: 26039107 [Abstract] [Full Text] [Related]
37. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis. Wu LM, Chen FY, Jiang XX, Gu HY, Yin Y, Xu JR. Eur J Radiol; 2012 Feb 01; 81(2):303-11. PubMed ID: 21145680 [Abstract] [Full Text] [Related]
38. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Györke T, Zajic T, Lange A, Schäfer O, Moser E, Makó E, Brink I. Nucl Med Commun; 2006 Jan 01; 27(1):17-24. PubMed ID: 16340719 [Abstract] [Full Text] [Related]
39. Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma? Andreani L, Ipponi E, Ruinato AD, Lupi T, Di Sacco F, Volterrani D, Coccoli L, Capanna R. Folia Med (Plovdiv); 2024 Apr 30; 66(2):196-202. PubMed ID: 38690814 [Abstract] [Full Text] [Related]
40. Recurrent Metastatic Ewing Sarcoma Involving Only in the Muscles of Extremities Shown on FDG PET/CT. Fleury AS, Zhuang H. Clin Nucl Med; 2024 Jun 01; 49(6):589-591. PubMed ID: 38537215 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]